About: Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1990 (uk) im Oktober 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1990 (ast) scientific article published on 01 October 1990 (en)
publication date	wds:Q68429082-4A97033C-C3B6-4B67-B692-DCAA8EC741D5
publication date	1990-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68429082-56F13DCC-2C68-490E-92CF-E36F225B212A
language of work or name	English
cites work	wds:Q68429082-06BEEB0F-A3A1-4D3F-BA98-3877C6F53EB9 wds:Q68429082-1534E6D9-9D5B-42A9-A8A1-EAD810FC9970 wds:Q68429082-1A659C88-2027-4ADB-A544-AF902F5C3009 wds:Q68429082-26179CEF-7DFB-4442-8310-603999B86923 wds:Q68429082-2F417CC6-29C2-4091-A564-EAAE39EC8356 wds:Q68429082-301FA0D5-289D-402C-8D3A-13C9E8CCF430 wds:Q68429082-30BD8A39-18E4-4FC3-AC04-BB376877F7BC wds:Q68429082-39B0E4DF-D020-45BB-9EB1-E623746CCF26 wds:Q68429082-3ECD93CE-46C1-492F-AB51-A4731BD3BFB1 wds:Q68429082-46AA24C6-EBB1-46C7-B7AA-8E8D21D7D12B wds:Q68429082-47F8C1F3-D696-4CEC-9EA3-AABF37F3C813 wds:Q68429082-4FE1D93F-479B-48EE-97C6-E83D862416F5 wds:Q68429082-55B53DD1-3779-44F8-9BA3-7BCA34A2687C wds:Q68429082-5C7A177E-72D4-4E4E-9342-9ADC94D7673B wds:Q68429082-5E22ACB1-2CB6-45D8-A96E-A889D8EB6F5D wds:Q68429082-6005E329-B7DE-477C-81B1-CF2D4305B4C7 wds:Q68429082-61A8D129-E051-4CF2-8492-0F80C37E7D56 wds:Q68429082-6213B11D-8DE6-44E0-A2AB-FCC1D65ABB10 wds:Q68429082-6AA87093-8995-4959-A320-D7E8B1CC7077 wds:Q68429082-6CC260DB-CBF0-4DE7-8A1F-B23743F0A713 wds:Q68429082-6DED6A39-8327-452D-9388-D433066D0C6A wds:Q68429082-78E27E9F-0396-403A-9ADA-3137572005C1 wds:Q68429082-91A21BD4-E5F1-4F97-9D65-10FAD69835F6 wds:Q68429082-A63E0B5F-AC3E-4854-BC42-4A266FB3B54F wds:Q68429082-B8C6864E-C762-4DF8-B3A6-F45FAB3A4CA4 wds:Q68429082-B9C53E13-E3F5-45BC-9A27-3E2A1517E9C9 wds:Q68429082-C03A422D-25C0-4A82-8FD8-BAB327834166 wds:Q68429082-C683DB17-42E6-48D4-A3C1-B5C39BC5D4F1 wds:Q68429082-CF843583-A259-42C7-8D03-348400799521 wds:Q68429082-D0DD4F4A-2423-40D8-B1AD-024B9F8EDBBB wds:Q68429082-EC3148E5-4413-4DEC-9736-324D6D121BC8 wds:Q68429082-EF23C837-ED9B-46C0-8489-48925897DBDF wds:Q68429082-F09D76F7-C1C8-4BEB-A9EC-51D24F7EEF20
cites work	Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications Radioimmunoassay of Prostaglandins Fα, E1and E2in Human Plasma Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor Continued incorporation of circulating radiolabeled fibrinogen into preformed coronary artery thrombi The biochemical pharmacology of thromboxane synthase inhibition in man. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. Thromboxane a2: biosynthesis and effects on platelets Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man Urinary excretion of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP Platelets interact with fibrin only after activation Iliac artery mural thrombus formation. Effect of antiplatelet therapy on 111In-platelet deposition in baboons
author name string	wds:Q68429082-0E76C50D-2484-47E6-9E51-6BE4E20AAA49 wds:Q68429082-8532AA9C-AA52-4C63-B723-EE3496A895A3 wds:Q68429082-96FABDD2-5AF0-4DB6-A79F-09A5E4AC0867 wds:Q68429082-E864DB81-AC39-4099-B763-97F4A40CBA2C wds:Q68429082-F6B46300-C8D0-47FA-8393-A0EEB167A4D8 wds:Q68429082-FEF5AD78-388F-4725-AC28-E7DF008A68A1 wds:Q68429082-FF31AE02-045D-4AB9-BB3D-7ABB141483A2
author name string	J McNatt J T Willerson L M Buja P Golino S K Yao M Rosolowsky F De Clerck
rdfs:label	Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (en) Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (nl)
skos:prefLabel	Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (en) Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (nl)
name	Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (en) Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a (nl)
title	wds:Q68429082-29B741BB-F8F3-45F9-8509-3EF63EB11B41
title	Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis (en)
page(s)	wds:Q68429082-4FDD5CCC-AB5D-4A0B-AB88-7711CD5BDDCE
page(s)	1095-1102

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software